Stay updated with breaking news from Nasdaq Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Standard BioTools Inc. (NASDAQ:LAB – Get Rating) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 2,600,000 shares, a decrease of 15.0% from the February 28th total of 3,060,000 shares. Based on an average daily trading volume, of 246,200 shares, […]
Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP...
-logo.png?v=20221121151525&w=240&h=240&zc=2){kind=logo}
Standard BioTools (NASDAQ:LAB – Get Rating) and Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. Profitability This table compares Standard BioTools and Olink […]
Standard BioTools (NASDAQ:LAB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Standard BioTools to related companies based on the strength of its profitability, earnings, analyst recommendations, risk, dividends, valuation and institutional ownership. Profitability This table compares […]
Standard BioTools (NASDAQ:LAB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Standard BioTools to related businesses based on the strength of its earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Analyst Recommendations This is […]